Literature DB >> 16837105

Abeta42 neurotoxicity in primary co-cultures: effect of apoE isoform and Abeta conformation.

Arlene M Manelli1, Lindsey C Bulfinch, Patrick M Sullivan, Mary Jo LaDu.   

Abstract

Autosomal dominant mutations that increase amyloid-beta(1-42) (Abeta42) cause familial Alzheimer's disease (AD), and the most common genetic risk factor for AD is the presence of the epsilon4 allele of apolipoprotein E (apoE). Previously, we characterized stable preparations of Abeta42 oligomers and fibrils and reported that oligomers induced a 10-fold greater increase in neurotoxicity than fibrils in Neuro-2A cells. To determine the effects of apoE genotype on Abeta42 oligomer- and fibril-induced neurotoxicity in vitro, we co-cultured wild type (WT) neurons with glia from WT, apoE-knockout (apoE-KO), and human apoE2-, E3-, and E4-targeted replacement (TR) mice. Dose-dependent neurotoxicity was induced by oligomeric Abeta42 with a ranking order of apoE4-TR>KO=apoE2-TR=apoE3-TR>WT. Neurotoxicity induced by staurosporine or glutamate were not affected by apoE genotype, indicating specificity for oligomeric Abeta42-induced neurotoxicity. These in vitro data demonstrate a gain of negative function for apoE4, synergistic with oligomeric Abeta42, in mediating neurotoxicity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16837105      PMCID: PMC3752940          DOI: 10.1016/j.neurobiolaging.2006.05.024

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  87 in total

Review 1.  Targeting small Abeta oligomers: the solution to an Alzheimer's disease conundrum?

Authors:  W L Klein; G A Krafft; C E Finch
Journal:  Trends Neurosci       Date:  2001-04       Impact factor: 13.837

Review 2.  Alzheimer's disease is a synaptic failure.

Authors:  Dennis J Selkoe
Journal:  Science       Date:  2002-10-25       Impact factor: 47.728

3.  TGFbeta1 enhances formation of cellular Abeta/apoE deposits in vascular myocytes.

Authors:  Bozena Mazur-Kolecka; Janusz Frackowiak; Harry Le Vine; Taraneh Haske; Lori Evans; Thirasak Sukontasup; Adam Golabek
Journal:  Neurobiol Aging       Date:  2003 Mar-Apr       Impact factor: 4.673

4.  Apolipoprotein E modulates Alzheimer's Abeta(1-42)-induced oxidative damage to synaptosomes in an allele-specific manner.

Authors:  Christopher M Lauderback; Jaroslaw Kanski; Janna M Hackett; Noboyo Maeda; Mark S Kindy; D Allan Butterfield
Journal:  Brain Res       Date:  2002-01-04       Impact factor: 3.252

Review 5.  Apolipoprotein E and apolipoprotein E receptors modulate A beta-induced glial neuroinflammatory responses.

Authors:  M J LaDu; J A Shah; C A Reardon; G S Getz; G Bu; J Hu; L Guo; L J Van Eldik
Journal:  Neurochem Int       Date:  2001 Nov-Dec       Impact factor: 3.921

6.  Purification and characterization of astrocyte-secreted apolipoprotein E and J-containing lipoproteins from wild-type and human apoE transgenic mice.

Authors:  R B DeMattos; R P Brendza; J E Heuser; M Kierson; J R Cirrito; J Fryer; P M Sullivan; A M Fagan; X Han; D M Holtzman
Journal:  Neurochem Int       Date:  2001 Nov-Dec       Impact factor: 3.921

7.  Oxidative damage is the earliest event in Alzheimer disease.

Authors:  A Nunomura; G Perry; G Aliev; K Hirai; A Takeda; E K Balraj; P K Jones; H Ghanbari; T Wataya; S Shimohama; S Chiba; C S Atwood; R B Petersen; M A Smith
Journal:  J Neuropathol Exp Neurol       Date:  2001-08       Impact factor: 3.685

Review 8.  Deciphering the genetic basis of Alzheimer's disease.

Authors:  Dennis J Selkoe; Marcia B Podlisny
Journal:  Annu Rev Genomics Hum Genet       Date:  2002-04-15       Impact factor: 8.929

Review 9.  The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.

Authors:  John Hardy; Dennis J Selkoe
Journal:  Science       Date:  2002-07-19       Impact factor: 47.728

10.  Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability.

Authors:  Karie N Dahlgren; Arlene M Manelli; W Blaine Stine; Lorinda K Baker; Grant A Krafft; Mary Jo LaDu
Journal:  J Biol Chem       Date:  2002-06-10       Impact factor: 5.157

View more
  35 in total

1.  Cerebrospinal Fluid Proteins as Regulators of Beta-amyloid Aggregation and Toxicity.

Authors:  Kayla M Pate; Regina M Murphy
Journal:  Isr J Chem       Date:  2017-01-18       Impact factor: 3.333

2.  Haptoglobin modulates beta-amyloid uptake by U-87 MG astrocyte cell line.

Authors:  Bernardetta Maresca; Maria Stefania Spagnuolo; Luisa Cigliano
Journal:  J Mol Neurosci       Date:  2014-11-18       Impact factor: 3.444

3.  Involvement of the Apoer2 and Lrp1 receptors in mediating the pathological effects of ApoE4 in vivo.

Authors:  Moran Gilat-Frenkel; Anat Boehm-Cagan; Ori Liraz; Xunde Xian; Joachim Herz; Daniel M Michaelson
Journal:  Curr Alzheimer Res       Date:  2014       Impact factor: 3.498

4.  APOE4-specific changes in Aβ accumulation in a new transgenic mouse model of Alzheimer disease.

Authors:  Katherine L Youmans; Leon M Tai; Evelyn Nwabuisi-Heath; Lisa Jungbauer; Takahisa Kanekiyo; Ming Gan; Jungsu Kim; William A Eimer; Steve Estus; G William Rebeck; Edwin J Weeber; Guojun Bu; Chunjiang Yu; Mary Jo Ladu
Journal:  J Biol Chem       Date:  2012-10-11       Impact factor: 5.157

5.  Microglia activated with the toll-like receptor 9 ligand CpG attenuate oligomeric amyloid {beta} neurotoxicity in in vitro and in vivo models of Alzheimer's disease.

Authors:  Yukiko Doi; Tetsuya Mizuno; Yuki Maki; Shijie Jin; Hiroyuki Mizoguchi; Masayoshi Ikeyama; Minoru Doi; Makoto Michikawa; Hideyuki Takeuchi; Akio Suzumura
Journal:  Am J Pathol       Date:  2009-10-15       Impact factor: 4.307

6.  Endocytic pathways mediating oligomeric Abeta42 neurotoxicity.

Authors:  Chunjiang Yu; Evelyn Nwabuisi-Heath; Kevin Laxton; Mary Jo Ladu
Journal:  Mol Neurodegener       Date:  2010-05-17       Impact factor: 14.195

7.  Systemic treatment with liver X receptor agonists raises apolipoprotein E, cholesterol, and amyloid-β peptides in the cerebral spinal fluid of rats.

Authors:  Sokreine Suon; Jie Zhao; Stephanie A Villarreal; Nikesh Anumula; Mali Liu; Linda M Carangia; John J Renger; Celina V Zerbinatti
Journal:  Mol Neurodegener       Date:  2010-10-29       Impact factor: 14.195

8.  Evidence of altered posteromedial cortical FMRI activity in subjects at risk for Alzheimer disease.

Authors:  Maija Pihlajamäki; Kelly O' Keefe; Lars Bertram; Rudolph E Tanzi; Bradford C Dickerson; Deborah Blacker; Marilyn S Albert; Reisa A Sperling
Journal:  Alzheimer Dis Assoc Disord       Date:  2010 Jan-Mar       Impact factor: 2.703

9.  In vivo and in vitro effects of an apolipoprotein e mimetic peptide on amyloid-β pathology.

Authors:  Shaila P Handattu; Candyce E Monroe; Gaurav Nayyar; Mayakonda N Palgunachari; Inga Kadish; Thomas van Groen; G M Anantharamaiah; David W Garber
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

10.  Microglia activation mediates fibrillar amyloid-β toxicity in the aged primate cortex.

Authors:  Elaine Leung; Ling Guo; Jing Bu; Marie Maloof; Joseph El Khoury; Changiz Geula
Journal:  Neurobiol Aging       Date:  2009-04-05       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.